Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib
Dermatitis
.
2023 Nov-Dec;34(6):567.
doi: 10.1089/derm.2022.0065.
Epub 2023 Feb 27.
Authors
Ashley Vander Does
1
,
Gil Yosipovitch
Affiliation
1
Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA.
PMID:
36847309
DOI:
10.1089/derm.2022.0065
No abstract available
MeSH terms
Humans
Neurodermatitis*
Prurigo* / drug therapy
Pruritus
Pyrimidines
Sulfonamides
Substances
abrocitinib
Pyrimidines
Sulfonamides